Schalken JA - Search Results

1

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy.

Haese A, de la Taille A, van Poppel H, Marberger M, Stenzl A, Mulders PF, Huland H, Abbou CC, Remzi M, Tinzl M, Feyerabend S, Stillebroer AB, van Gils MP, Schalken JA. Haese A, et al. Among authors: schalken ja. Eur Urol. 2008 Nov;54(5):1081-8. doi: 10.1016/j.eururo.2008.06.071. Epub 2008 Jun 26. Eur Urol. 2008. PMID: 18602209

2

Identification of new prostate cancer progression markers by differential hybridization analysis.

Schalken JA, Debruyne FM. Schalken JA, et al. Eur Urol. 1992;21 Suppl 1:60-5. doi: 10.1159/000474893. Eur Urol. 1992. PMID: 1425840 Review.

3

The Heinrich Warner Prize 1989: the use of differential hybridization analysis to identify markers for diagnosis of urogenital cancer.

Schalken JA. Schalken JA. Eur Urol. 1990;18 Suppl 2:52-7. doi: 10.1159/000463965. Eur Urol. 1990. PMID: 2226612 Review. No abstract available.

4

Tumor heterogeneity as prognostic factor in patients with low-stage (T1-3N0M0) renal-cell carcinoma.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: schalken ja. Investig Urol (Berl). 1994;5:60-5. Investig Urol (Berl). 1994. PMID: 7719322 No abstract available.

5

Karyometric analysis of intra-tumour heterogeneity in prostate adenocarcinoma.

van der Poel HG, Mulders PF, Aalders TW, Oosterhof GO, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Anal Cell Pathol. 1994 Aug;7(2):153-70. Anal Cell Pathol. 1994. PMID: 7993825

6

Prognostic value of karyometric and clinical characteristics in renal cell carcinoma. Quantitative assessment of tumor heterogeneity.

van der Poel HG, Mulders PF, Oosterhof GO, Schaafsma HE, Hendriks JC, Schalken JA, Debruyne FM. van der Poel HG, et al. Among authors: schalken ja. Cancer. 1993 Nov 1;72(9):2667-74. doi: 10.1002/1097-0142(19931101)72:9<2667::aid-cncr2820720924>3.0.co;2-0. Cancer. 1993. PMID: 8402488

7

New perspectives in the treatment of prostate cancer.

Schalken JA. Schalken JA. Eur Urol. 1997;31 Suppl 2:20-3. doi: 10.1159/000474544. Eur Urol. 1997. PMID: 9074907

8

Intratumoral nuclear morphologic heterogeneity in prostate cancer.

van der Poel HG, Oosterhof GO, Schaafsma HE, Debruyne FM, Schalken JA. van der Poel HG, et al. Among authors: schalken ja. Urology. 1997 Apr;49(4):652-7. doi: 10.1016/s0090-4295(96)00557-2. Urology. 1997. PMID: 9111646 Free article.

9

Influence of high-intensity focused ultrasound on the development of metastases.

Oosterhof GO, Cornel EB, Smits GA, Debruyne FM, Schalken JA. Oosterhof GO, et al. Among authors: schalken ja. Eur Urol. 1997;32(1):91-5. Eur Urol. 1997. PMID: 9266238

10

Urinary NMP22 and karyometry in the diagnosis and follow-up of patients with superficial bladder cancer.

Witjes JA, van der Poel HG, van Balken MR, Debruyne FM, Schalken JA. Witjes JA, et al. Among authors: schalken ja. Eur Urol. 1998;33(4):387-91. doi: 10.1159/000019621. Eur Urol. 1998. PMID: 9612682

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

420 results

Search Page